From Pathogen to Infectious Disease Diagnosis: Multispecies Immunoblot Nearly Doubles Early Lyme Disease Detection

FDA-cleared single-step immunoblot tests built on recombinant antigens from multiple Borrelia species detected nearly twice as many early Lyme disease cases as standard two-tier testing. Joseph J. Burrascano Jr, MD, offers insights into what the new tests mean for clinicians.